Physician profile
Lloyd E Hepburn
NPI 1770531972
$4,390.08
in general payments reported to CMS, 2019-2025
39 companies · $626 in 2025
The $626 reported for 2025 was more than what 77% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $628 · 2020: $221 · 2021: $252 · 2022: $599 · 2023: $1,012 · 2024: $1,051 · 2025: $626.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,690.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,689.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $726.46 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Novo Nordisk INC | $549.77 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $400.20 | 2019-2025 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $350.57 | 2021-2025 | |
| Amgen INC. | $222.91 | 2019-2025 | Repatha, Krystexxa, Evenity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $208.50 | 2019-2025 | Jardiance |
| Pfizer INC. | $207.70 | 2020-2025 | |
| Glaxosmithkline, LLC. | $200.59 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Abbvie INC. | $181.09 | 2021-2025 | |
| Dexcom, INC. | $178.39 | 2024 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $138.38 | 2023-2024 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $105.70 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $96.56 | 2019-2023 | |
| Abbott Laboratories | $88.29 | 2021-2025 | Eterna |
| Ironwood Pharmaceuticals, INC | $85.48 | 2022-2024 | Linzess |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lloyd Hepburn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.